In Silico Evaluation of a Promising Key Intermediate Thieno [2,3-d] Pyrimidine Derivative with Expected JAK2 Kinase Inhibitory Activity
- Supplementary File 1:
3D structure (MOL, 4 KiB)
Display in JSmol Viewer
3D structure generated by CORINA Classic by MN-AM. - Supplementary File 2:
INCHI-Document (INCHI, 1 KiB)
- Supplementary File 3:
MOL-Document (MOL, 4 KiB)
Display in JSmol Viewer
Elmongy, E.I.; Henidi, H.A. In Silico Evaluation of a Promising Key Intermediate Thieno [2,3-d] Pyrimidine Derivative with Expected JAK2 Kinase Inhibitory Activity. Molbank 2022, 2022, M1352. https://doi.org/10.3390/M1352
Elmongy EI, Henidi HA. In Silico Evaluation of a Promising Key Intermediate Thieno [2,3-d] Pyrimidine Derivative with Expected JAK2 Kinase Inhibitory Activity. Molbank. 2022; 2022(1):M1352. https://doi.org/10.3390/M1352
Chicago/Turabian StyleElmongy, Elshaymaa I., and Hanan A. Henidi. 2022. "In Silico Evaluation of a Promising Key Intermediate Thieno [2,3-d] Pyrimidine Derivative with Expected JAK2 Kinase Inhibitory Activity" Molbank 2022, no. 1: M1352. https://doi.org/10.3390/M1352